Found: 10
Select item for more details and to access through your institution.
Secukinumab demonstrates high and sustained efficacy in nail psoriasis: post hoc analysis from phase III trials in patients with psoriatic arthritis.
- Published in:
- British Journal of Dermatology, 2022, v. 187, n. 3, p. 438, doi. 10.1111/bjd.21233
- By:
- Publication type:
- Article
Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression in methotrexate (MTX)-naive patients with Early Erosive rheumatoid arthritis (AGREE)
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0671-9
- By:
- Publication type:
- Article
Attainment and characteristics of clinical remission according to the new ACR-EULAR criteria in abatacept-treated patients with early rheumatoid arthritis: new analyses from the Abatacept study to Gauge Remission and joint damage progression...
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 157, doi. 10.1186/s13075-015-0671-9
- By:
- Publication type:
- Article
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study.
- Published in:
- Rheumatology, 2024, v. 63, n. 1, p. 41, doi. 10.1093/rheumatology/kead181
- By:
- Publication type:
- Article
Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE.
- Published in:
- Rheumatology, 2022, v. 61, n. 5, p. 1867, doi. 10.1093/rheumatology/keab628
- By:
- Publication type:
- Article
255 Secukinumab provides rapid and sustained resolution of enthesitis in psoriatic arthritis patients: pooled analysis of two Phase 3 studies, FUTURE 2 and FUTURE 3.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
254 Impact of secukinumab treatment on psoriatic arthritis patients with or without enthesitis at baseline: pooled data from FUTURE 2 AND FUTURE 3 Phase 3 studies.
- Published in:
- 2019
- By:
- Publication type:
- Abstract
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies.
- Published in:
- Rheumatology & Therapy, 2021, v. 8, n. 1, p. 273, doi. 10.1007/s40744-020-00269-6
- By:
- Publication type:
- Article
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-2055-z
- By:
- Publication type:
- Article